RA CAPITAL MANAGEMENT, L.P. bought CLYM

September 28, 2026 · Form 4 insider transaction

RA CAPITAL MANAGEMENT, L.P. bought 10,000 shares of Climb Bio Inc at $3.46 per share, a transaction worth $34.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
10,000
Price
$3.46
Total value
$34.6K
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 28, 2026
Filing dateSeptember 30, 2026
Shares owned after10,000
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund, L.P. (the "Nexus Fund"), RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"), RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund, the Nexus Fund II, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.; This option was granted to Andrew Levin pursuant to the Issuer's non-employee director compensation policy. Under Dr. Levin's arrangement with the Adviser, Dr. Levin held the option for the benefit of the Fund, the Nexus Fund, the Nexus Fund II, the Nexus Fund III, and the Account. Dr. Levin is obligated to turn over to the Adviser any stock received upon exercise of the option, which will offset advisory fees owed by the Fund to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock.

View the original Form 4 on SEC EDGAR